Department of Medicine
Jagoda Jasielec specializes in hematology and oncology. Her academic interests include the role and implementation of minimal residual disease testing in myeloma; development of novel therapies in relapsed and refractory patients, including chimeric antigen receptor (CAR) T-cell therapy; and the development and incorporation of information on genetic risk for myeloma into clinical care.
Her research has been published in Leukemia & Lymphoma, Molecular Cancer Therapeutics, British Journal of Haematology, Haematologica, Journal of Clinical Oncology, Leukemia, International Journal of Hematology and Oncology, Seminars in Oncology, and Clinical and Translational Science.
Jasielec received her MD from Jagiellonian University Medical College in Kraków, Poland. She completed her residency in internal medicine at the University of Vermont, as well as a fellowship in hematology and oncology at the University of Chicago Medicine, where her clinical interests were focused on multiple myeloma.